Recall Register

Drug recall: Pitavastatin Tablets, 1 mg, 90 Tablets per bottle, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC…

Class III FDA enforcement event 97160. Recall start date: . Status in the FDA record: Ongoing.

Reason for recall, in the words of FDA

Failed Impurity/Degradation Specifications

Class III, in the words of FDA

a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences

AvKARE started this drug recall on 26 Jun 2025. The firm address in the FDA record is in Pulaski, TN. FDA put the recall in Class III. FDA event 97160 has 2 product records. The first FDA enforcement report date is 9 Jul 2025. The record gives the status Ongoing. 59 of the 322 drug events that started in 2025 have more product records. The median drug event of 2025 has 1 product record. The openFDA file has 322 drug events that started in 2025 and 319 that started in 2024.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide in the USA

Recalling firm

AvKARE, Pulaski, TN.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

2 product records in the event.

FDA event 97160: product records
Recall numberProductQuantityClassStatusReport date
D-0528-2025Pitavastatin Tablets, 1 mg, 90 Tablets per bottle, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 42291-905-901,560 bottlesClass IIIOngoing9 Jul 2025
D-0529-2025Pitavastatin Tablets, 2 mg, 90 Tablets per bottle, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 42291-906-908,573 bottlesClass IIIOngoing9 Jul 2025

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class III: The lowest of the three FDA recall classes.

The event in context

Drug events that started in 2025
322
Share of these events in Class III
12%
Product records in this event
2Median of the firm: 1
Events of the firm on the register
14

Other events of the firm

Other FDA enforcement events of AvKARE
InitiatedProduct (first record)TypeClassRecords
13 Feb 2026Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38DrugClass II1
31 Dec 2025Rosuvastatin Tablets, USP, 10 mg, Rx Only, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, DrugClass II1
2 Sep 2025Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3 Units, 3x2DrugClass II1
25 Aug 2025chloroproMAZINE Hydrochloride Tablets, USP, 50 mg, 50 Tablets (5x10) unit dose carton, Rx only, Manufactured for: AvKareDrugClass II2
13 May 2025Celecoxib Capsules, 200 mg, 50 Capsules (5x10) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Pulaski, TN 3847DrugClass II1
9 May 2025Chlorthalidone Tablets, USP, 25 mg, 50 Tablets (5x10) Unit Dose cards per carton, Rx only, Manufactured for: AvKARE, PulDrugClass II1
4 Feb 2025Silodosin Capsules, 8mg, 90-count bottle, Rx only, Manufactured for: AvKare, Pulaski, TN 38478, Manufactured by: Amneal DrugClass II1
21 Jan 2025Irbesartan Tablets USP, 300 mg, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDrugClass II1
18 Dec 2024Carboxymethylcellulose Sodium Ophthalmic Solution 0.5% Moisturizing Lubricant Eye Drops, 0.5 FL OZ (15 mL) bottles, DistDrugClass III2
4 Dec 2024Nitrofurantoin Capsules, USP, 100 mg, 50 Capsules (5 x 10) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Inc.DrugClass II1

AvKARE: all 14 events

Official channels

Cite this page

Recall Register. FDA enforcement event 97160. https://recallregister.com/fda/iii/97160/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide in the USA
What quantity of product is in FDA event 97160?
The event has 2 product records. The first record gives this quantity: 1,560 bottles
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2025 have the same class?
12% of the 322 drug events that started in 2025 are in Class III.